GLOBAL CANCER DRUG BASED ON CAR-T MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Sep 2021 73
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cancer Drug based on CAR-T
1.2 Classification of Cancer Drug based on CAR-T by Type
1.2.1 Overview: Global Cancer Drug based on CAR-T Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Drug based on CAR-T Revenue Market Share by Type in 2020
1.2.3 Allogeneic
1.2.4 Autologous
1.3 Global Cancer Drug based on CAR-T Market by Application
1.3.1 Overview: Global Cancer Drug based on CAR-T Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Cancer Drug based on CAR-T Market Size & Forecast
1.5 Global Cancer Drug based on CAR-T Market Size and Forecast by Region
1.5.1 Global Cancer Drug based on CAR-T Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Drug based on CAR-T Market Size by Region, (2016-2021)
1.5.3 North America Cancer Drug based on CAR-T Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Drug based on CAR-T Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Drug based on CAR-T Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Drug based on CAR-T Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Drug based on CAR-T Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Drug based on CAR-T Market Drivers
1.6.2 Cancer Drug based on CAR-T Market Restraints
1.6.3 Cancer Drug based on CAR-T Trends Analysis
2 Company Profiles
2.1 Fosun Kite Biotechnology
2.1.1 Fosun Kite Biotechnology Details
2.1.2 Fosun Kite Biotechnology Major Business
2.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product and Solutions
2.1.4 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Fosun Kite Biotechnology Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Cancer Drug based on CAR-T Product and Solutions
2.2.4 Gilead Sciences Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Cancer Drug based on CAR-T Product and Solutions
2.3.4 Novartis Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Product and Solutions
2.4.4 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Drug based on CAR-T Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Drug based on CAR-T Players Market Share
3.2.2 Top 10 Cancer Drug based on CAR-T Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Drug based on CAR-T Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Drug based on CAR-T Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Drug based on CAR-T Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Drug based on CAR-T Revenue Market Share by Application (2016-2021)
5.2 Cancer Drug based on CAR-T Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Drug based on CAR-T Revenue by Type (2016-2026)
6.2 North America Cancer Drug based on CAR-T Revenue by Application (2016-2026)
6.3 North America Cancer Drug based on CAR-T Market Size by Country
6.3.1 North America Cancer Drug based on CAR-T Revenue by Country (2016-2026)
6.3.2 United States Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Drug based on CAR-T Revenue by Type (2016-2026)
7.2 Europe Cancer Drug based on CAR-T Revenue by Application (2016-2026)
7.3 Europe Cancer Drug based on CAR-T Market Size by Country
7.3.1 Europe Cancer Drug based on CAR-T Revenue by Country (2016-2026)
7.3.2 Germany Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
7.3.3 France Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Drug based on CAR-T Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Drug based on CAR-T Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Drug based on CAR-T Market Size by Region
8.3.1 Asia-Pacific Cancer Drug based on CAR-T Revenue by Region (2016-2026)
8.3.2 China Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8.3.5 India Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Drug based on CAR-T Revenue by Type (2016-2026)
9.2 South America Cancer Drug based on CAR-T Revenue by Application (2016-2026)
9.3 South America Cancer Drug based on CAR-T Market Size by Country
9.3.1 South America Cancer Drug based on CAR-T Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Drug based on CAR-T Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Drug based on CAR-T Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Drug based on CAR-T Market Size by Country
10.3.1 Middle East & Africa Cancer Drug based on CAR-T Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Drug based on CAR-T Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Cancer Drug based on CAR-T Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Drug based on CAR-T Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Drug based on CAR-T Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Drug based on CAR-T Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Drug based on CAR-T Revenue Market Share by Region (2021-2026)
Table 6. Fosun Kite Biotechnology Corporate Information, Head Office, and Major Competitors
Table 7. Fosun Kite Biotechnology Major Business
Table 8. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product and Solutions
Table 9. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences Cancer Drug based on CAR-T Product and Solutions
Table 13. Gilead Sciences Cancer Drug based on CAR-T Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Cancer Drug based on CAR-T Product and Solutions
Table 17. Novartis Cancer Drug based on CAR-T Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Cancer Drug based on CAR-T Product and Solutions
Table 21. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Cancer Drug based on CAR-T Revenue (USD Million) by Players (2019-2021)
Table 23. Global Cancer Drug based on CAR-T Revenue Share by Players (2019-2021)
Table 24. Breakdown of Cancer Drug based on CAR-T by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Cancer Drug based on CAR-T Players Head Office, Products and Services Provided
Table 26. Cancer Drug based on CAR-T Mergers & Acquisitions in the Past Five Years
Table 27. Cancer Drug based on CAR-T New Entrants and Expansion Plans
Table 28. Global Cancer Drug based on CAR-T Revenue (USD Million) by Type (2016-2021)
Table 29. Global Cancer Drug based on CAR-T Revenue Share by Type (2016-2021)
Table 30. Global Cancer Drug based on CAR-T Revenue Forecast by Type (2021-2026)
Table 31. Global Cancer Drug based on CAR-T Revenue by Application (2016-2021)
Table 32. Global Cancer Drug based on CAR-T Revenue Forecast by Application (2021-2026)
Table 33. North America Cancer Drug based on CAR-T Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Cancer Drug based on CAR-T Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Cancer Drug based on CAR-T Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Cancer Drug based on CAR-T Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Cancer Drug based on CAR-T Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Cancer Drug based on CAR-T Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Cancer Drug based on CAR-T Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Cancer Drug based on CAR-T Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Cancer Drug based on CAR-T Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Cancer Drug based on CAR-T Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Cancer Drug based on CAR-T Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Cancer Drug based on CAR-T Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Cancer Drug based on CAR-T Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Cancer Drug based on CAR-T Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Cancer Drug based on CAR-T Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Cancer Drug based on CAR-T Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Cancer Drug based on CAR-T Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Cancer Drug based on CAR-T Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Cancer Drug based on CAR-T Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Cancer Drug based on CAR-T Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Cancer Drug based on CAR-T Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Cancer Drug based on CAR-T Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Cancer Drug based on CAR-T Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Cancer Drug based on CAR-T Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Cancer Drug based on CAR-T Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Cancer Drug based on CAR-T Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Cancer Drug based on CAR-T Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Cancer Drug based on CAR-T Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Cancer Drug based on CAR-T Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Cancer Drug based on CAR-T Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Drug based on CAR-T Picture
Figure 2. Global Cancer Drug based on CAR-T Revenue Market Share by Type in 2020
Figure 3. Allogeneic
Figure 4. Autologous
Figure 5. Cancer Drug based on CAR-T Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Other Picture
Figure 9. Global Cancer Drug based on CAR-T Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Cancer Drug based on CAR-T Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Cancer Drug based on CAR-T Revenue Market Share by Region (2016-2026)
Figure 12. Global Cancer Drug based on CAR-T Revenue Market Share by Region in 2020
Figure 13. North America Cancer Drug based on CAR-T Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Cancer Drug based on CAR-T Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Cancer Drug based on CAR-T Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Cancer Drug based on CAR-T Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Cancer Drug based on CAR-T Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Cancer Drug based on CAR-T Market Drivers
Figure 19. Cancer Drug based on CAR-T Market Restraints
Figure 20. Cancer Drug based on CAR-T Market Trends
Figure 21. Fosun Kite Biotechnology Recent Developments and Future Plans
Figure 22. Gilead Sciences Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Global Cancer Drug based on CAR-T Revenue Share by Players in 2020
Figure 26. Cancer Drug based on CAR-T Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Cancer Drug based on CAR-T Revenue Market Share in 2020
Figure 28. Global Top 10 Players Cancer Drug based on CAR-T Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Cancer Drug based on CAR-T Revenue Share by Type in 2020
Figure 31. Global Cancer Drug based on CAR-T Market Share Forecast by Type (2021-2026)
Figure 32. Global Cancer Drug based on CAR-T Revenue Share by Application in 2020
Figure 33. Global Cancer Drug based on CAR-T Market Share Forecast by Application (2021-2026)
Figure 34. North America Cancer Drug based on CAR-T Sales Market Share by Type (2016-2026)
Figure 35. North America Cancer Drug based on CAR-T Sales Market Share by Application (2016-2026)
Figure 36. North America Cancer Drug based on CAR-T Revenue Market Share by Country (2016-2026)
Figure 37. United States Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Cancer Drug based on CAR-T Sales Market Share by Type (2016-2026)
Figure 41. Europe Cancer Drug based on CAR-T Sales Market Share by Application (2016-2026)
Figure 42. Europe Cancer Drug based on CAR-T Revenue Market Share by Country (2016-2026)
Figure 43. Germany Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Cancer Drug based on CAR-T Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Cancer Drug based on CAR-T Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Cancer Drug based on CAR-T Revenue Market Share by Region (2016-2026)
Figure 51. China Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Cancer Drug based on CAR-T Sales Market Share by Type (2016-2026)
Figure 58. South America Cancer Drug based on CAR-T Sales Market Share by Application (2016-2026)
Figure 59. South America Cancer Drug based on CAR-T Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Cancer Drug based on CAR-T Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Cancer Drug based on CAR-T Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Cancer Drug based on CAR-T Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Cancer Drug based on CAR-T Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source

Table of Contents

Related reports :

(Sep 21)

The Penicillin Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-leve...

(Sep 21)

The Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segment...

(Sep 21)

The Flavored Veterinary Medication market report provides a detailed analysis of global market size, regional and country-level market size,...

(Sep 21)

The Cannabis Extraction market report provides a detailed analysis of global market size, regional and country-level market size, segmentati...

(Sep 21)

The Hormone Replacement Therapy market report provides a detailed analysis of global market size, regional and country-level market size, se...

(Sep 21)

The Clozapine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market ...

Global Info Research

GLOBAL CANCER DRUG BASED ON CAR-T MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy